Potentiation of granulocyte colony-stimulating factor-induced mobilization of circulating progenitor cells by seven-day pretreatment with interleukin-3

Blood

Volumn 87, Issue 7, 1996, Pages 2732-2739

  Geissler, Klaus ^a   Peschel, Christian ^b   Niederwieser, Dietger ^b   Strobl, Herbert ^b   Goldschmitt, Jutta ^b   Öhler, Leopold ^b   Bettelheim, Peter ^b   Kalhs, Peter ^b   Huber, Christoph ^b   Lechner, Klaus ^b   Höcker, Paul ^b   Kolbe, Karin ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CHLORMETHINE; CYCLOPHOSPHAMIDE; PREDNISONE; PROCARBAZINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 3; VINCRISTINE SULFATE;

ADULT; ARTICLE; BLOOD CELL COUNT; BONE MARROW SUPPRESSION; BONE PAIN; BURST FORMING UNIT E; CANCER CHEMOTHERAPY; CELL TRANSPLANTATION; CLINICAL ARTICLE; COLONY FORMING UNIT GM; CONJUNCTIVITIS; DRUG POTENTIATION; FEMALE; FEVER; HEADACHE; HEMATOPOIETIC STEM CELL; HODGKIN DISEASE; HUMAN; LEUKAPHERESIS; MALE; MYALGIA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 9244231292     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.7.2732.bloodjournal8772732     Document Type: Article

References (33)

1. To LB, Robert M, Haylock DN, Dyson PG, Branford AL, Thorp D, Ho JQK, Dart GW, Horvath N, Davy MLJ, Olweny CLM, Abdi E, Juttner CA: Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 9:277, 1992
2. Gianni AM, Bregni M, Stern AC, Bonadonna G, Siena S, Tarella C, Pileri A: Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet 9:580, 1989
3. Sheridan WP, Begley CG, Juttner CA, Szer J, To LB, Maher D, McGrath KM, Morstyn G, Fox RM: Effect of peripheral-blood progentior cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 3:640, 1992
4. Peters WP, Rosner G, Ross M, Vredenburgh J, Meisenberg B, Gilbert C, Kurtzberg J: Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. Blood 81:1709, 1993
5. Elias AD, Ayash L, Anderson KC, Hunt M, Wheeler C, Schwartz G, Tepler I, Mazanet R, Lynch C, Pap S, Pelaez J, Reich E, Critchlow J, Demetri G, Bibbo J, Schnipper L, Griffin JD, Frei E III, Antman KH: Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer. Blood 79:3036, 1992
6. Fukuda M, Kojima S, Matsumoto K, Matsuyama T: Autotransplantation of peripheral blood stem cells mobilized by chemotherapy and recombinant human granulocyte colony-stimulating factor in childhood neuroblastoma and non-Hodgkin's lymphoma. Br J Haematol 80:327, 1992
7. Socinski MA, Elias A, Schnipper L, Cannistra SA, Antman KH, Griffin JD: Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet 5:1194, 1988
8. Dührsen U, Villeval JL, Boyd J, Kannourakis G, Morstyn G, Metcalf D: Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood 72:2074, 1988
9. Chao NJ, Schriber JR, Grimes K, Long GD, Negrin RC, Raimondi CM, Horning SJ, Brown SL, Miller H, Blum KG: Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood 81:2031, 1993
10. Weaver CH, Buckner CD, Longin K, Appelbaum FR, Rowley S, Lilleby K, Miser J, Storb R, Hansen JA, Bensinger W: Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Blood 82:1981, 1993
11. Geissler K, Valent P, Mayer P, Liehl E, Hinterberger W, Lechner K, Bettelheim P: Recombinant human interleukin-3 expands the pool of circulating hematopoietic progenitor cells in primates-synergism with recombinant human granulocyte/macrophage colony-stimulating factor. Blood 75:2305, 1990
12. Griffin JD, Sullivan R, Beveridge R, Larcom P, Schlossman SF: Induction of proliferation of purified human myeloid progenitor cells: A rapid assay for granulocyte colony stimulating-factors. Blood 63:904, 1984
13. Levin J, Bang FB: Clottable protein in limulus: Its localization and kinetics of its coagulation by endotoxin. Thromb Diath Haemor 19:186, 1968
14. Souza LM, Boone TC, Gabrilove J, Lai PH, Zsebo KM, Murdock DC, Chazin VR, Bruszewski J, Lu H, Chen KK, Barendt J, Platzer E, Moore M, Mertelsmann R, Welte K: Recombinant human granulocyte colony-stimulating factor: Effects on normal and leukemic myeloid cells. Science 232:61, 1986
15. Fauser AA, Messer HA: Identification of megakaryocytes, macrophages, and eosinophils in colonies of human bone marrow containing neutrophilic granulocytes and erythroblasts. Blood 53:1023, 1979
16. + normal hematopoietic cells. Blood 82:2069, 1993
17. Colwill R, Crump M, Couture F, Danish R, Stewart AK, Sutton DMC, Scott JG, Sutcliffe SB, Brandwein JM, Keating A: Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease before intensive therapy and autologous bone marrow transplantation. J Clin Oncol 13:396, 1995
18. DeLuca E, Sheridan WP, Watson D, Szer J, Begley CG: Prior chemotherapy does not prevent effective mobilisation by G-CSF of peripheral blood progenitor cells. Br J Cancer 66:893, 1992
19. Mayer P, Valent P, Schmidt G, Liehl E, Bettelheim P: The in vivo effects of recombinant human interleukin-3: Demonstration of basophil differentiation factor, histamine producing activity, and priming of GM-CSF-responsive progenitors in nonhuman primates. Blood 74:613, 1989
20. Taketazu F, Chiba S, Shibuya K, Kuwaki T, Tsumura H, Miyazono K, Miyagawa K, Takaku F: IL-3 specifically inhibits GM-CSF binding to the higher affinity receptor. J Cell Physiol 146:251, 1991
21. Geissler K, Peschel C, Niederwieser D, Goldschmitt J, Hladik F, Fritz A, Öhler L, Bettelheim P, Huber C, Lechner K, Höcker P, Kolbe K: Effect of interleukin-3 pretreatment of granulocyte/ macrophage colony-stimulating factor induced mobilisation of circulating haemopoietic progenitor cells. Br J Haematol 91:299, 1995
22. Ottmann OG, Ganser A, Seipelt G, Eder M, Schulz G, Hoelzer D: Effects of recombinant human interleukin-3 on human hematopoietic progenitor and precursor cells in vivo. Blood 76:1494, 1990
23. Sniecinski I, Nowicki B, Nademanee A, Somlo G, Forman SJ: A comparison between 5 μg/kg and 10 μg/kg G-CSF for peripheral blood stem cell mobilization, in: Recent Advances in Hematopoietic Stem Cell Transplantation - Clinical Progress, New Technologies and Gene Therapy. San Diego, CA, 1993, p 238
24. Geissler K, Forstinger Ch, Kalhs P, Knobl P, Kier P, Kyrle P, Lechner K: Effect of interleukin-3 on responsiveness to granulocyte-colony-stimulating factor in severe aplastic anemia. Ann Intern Med 117:223, 1992
25. Donahuc RE, Seehra J, Metzger M, Lefebvre D, Rock B, Carbone S, Nathan DG, Garnick M, Sehgal PK, Laston D, LaVallie E, McCoy J, Schendel PF, Norton C, Turner K, Yang YC, Clark SC: Human IL-3 and GM-CSF act synergistically in stimulating hematopoiesis in primates. Science 241:1820, 1988
26. Umemura T, Al-Khatti A, Donahue RE, Papayannopoulou T, Stamatoyannopoulos G: Effects of interleukin-3 and erythropoietin on in vivo erythropoiesis and F-cell formation in primates. Blood 74:1571, 1989
27. Geissler K, Valent P, Bettelheim P, Sillaber Ch, Wagner B, Kyrle P, Hinterberger W, Lechner K, Liehl E, Mayer P: In vivo synergism of recombinant human interleukin-3 and recombinant human interleukin-6 on thrombopoiesis in primates. Blood 79:1155, 1992
28. Ganser A, Lindemann A, Ottmann OG, Seipelt G, Hess U, Geissler G, Kanz L, Frisch J, Schulz G, Herrmann F, Mertelsmann R, Hoelzer D: Sequential in vivo treatment with two recombinant human hematopoietic growth factors (interleukin-3 and granulocyte-macrophage colony-stimulating factor) as a new therapeutic modality to stimulate hematopoiesis: results of a phase I study. Blood 79:2583, 1992
29. Andrews R, Knitter G, Bartelmez S, Langley K, Farrar D, Hendren R, Appelbaum F, Bernstein I, Zsebo K: Recombinant human stem cell factor, a c-kit ligand, stimulates hematopoiesis in primates. Blood 78:1975, 1991
30. Andrews RG, Bridell RA, Knitter GH, Opie T, Bronsden M, Myerson D, Appelbaum FR, McNiece IK: In vivo synergy between recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in baboons: Enhanced circulation of progenitor cells. Blood 84:800, 1994
31. Siena S, Bregni M, Brando B, Belli N, Ravagnani F, Gandola L, Stern AC, Lansdorp PM, Bonadonna G, Gianni AM: Flow cytometry for clinical estimation of circulating hematopoielic progenitors for autologous transplantation in cancer patients. Blood 77:400, 1991
32. Bender J, Bik To L, Williams S, Schwartzberg LS: Defining a therapeutic dose of peripheral blood stem cells. J Hematother 1:329, 1992
33. Molineux G, Pojda Z, Hampson IN, Lord BI, Dexter TM: Transplantation potential of peripheral blood stem cells induced by granulocyte colony stimulating factor. Blood 76:2153, 1990